Scaffold for mesenchymal stem cell attachment and differentiation

The term "Scaffold for mesenchymal stem cell attachment and differentiation" is not a specific named molecular entity, protein, receptor, or enzyme, and therefore is not considered a direct therapeutic target. Instead, it is a functional description referring to biomaterials, such as extracellular matrix (ECM) scaffolds, that are engineered to support the attachment, proliferation, and differentiation of mesenchymal stem cells (MSCs). While these scaffolds are critical in regenerative medicine and tissue engineering, they themselves are not molecular targets that drugs would directly interact with in a pharmacological sense. The underlying biological processes of MSC differentiation, however, involve numerous therapeutic targets including transcription factors (e.g., Runx2, Sox9, PPARγ, Smad family members), growth factors (e.g., BMPs, TGF-β, FGF), signaling proteins (e.g., Wnt pathway components, β-catenin, TAZ), and mechanical sensors (e.g., integrins, focal adhesions, cytoskeletal components).